Dr Peter Kirk reported to the haemophilia centre directors on the third trial of prophylactic treatment of patients at Treloar's. Read more about Dr Peter Kirk reported to the haemophilia centre directors on the third trial of prophylactic treatment of patients at Treloar's.
Professor Tuddenham became aware of the association between people with haemophilia receiving factor concentrates and AIDS. Read more about Professor Tuddenham became aware of the association between people with haemophilia receiving factor concentrates and AIDS.
Professor Tuddenham told the Inquiry that DDAVP was not used regularly at the Royal Free until some time after 1980. Read more about Professor Tuddenham told the Inquiry that DDAVP was not used regularly at the Royal Free until some time after 1980.
Professor Tuddenham accepted in hindsight that the risk of factor concentrates transmitting blood-borne infections was not sufficiently appreciated. Read more about Professor Tuddenham accepted in hindsight that the risk of factor concentrates transmitting blood-borne infections was not sufficiently appreciated.
Reference centre directors agreed that DHSS representatives who were invited to attend Haemophilia Reference Centre Directors meetings for specific purposes as observers should only receive that part of the minutes which referred to the items for which they had been invited to attend and to which they had made a contribution. Read more about Reference centre directors agreed that DHSS representatives who were invited to attend Haemophilia Reference Centre Directors meetings for specific purposes as observers should only receive that part of the minutes which referred to the items for which they had been invited to attend and to which they had made a contribution.
Reference centre directors discussed the question of taking part in TV programmes, noting that such programmes could distort facts and present biased views. Read more about Reference centre directors discussed the question of taking part in TV programmes, noting that such programmes could distort facts and present biased views.
The first meeting of the reference centre directors discussed difficulties concerning the use and supply of Factor 8. Read more about The first meeting of the reference centre directors discussed difficulties concerning the use and supply of Factor 8.
Professor Ingram told the reference centre directors that "he had taken advice from the Medical Defence Union about home therapy and the ruling was that if a policy taken by a doctor (e.g. to institute home therapy) were one which he honestly thought to be best for his patient then the Medical Defence Union would defend him. Another organisation thought that the patient introduced to home therapy should have the risks and advantages of home therapy carefully explained to him." Read more about Professor Ingram told the reference centre directors that "he had taken advice from the Medical Defence Union about home therapy and the ruling was that if a policy taken by a doctor (e.g. to institute home therapy) were one which he honestly thought to be best for his patient then the Medical Defence Union would defend him. Another organisation thought that the patient introduced to home therapy should have the risks and advantages of home therapy carefully explained to him."
Regular meetings of the reference centre directors began. Read more about Regular meetings of the reference centre directors began.
The Reference Centre Directors noted that Drs Dormandy and Delamore had patients on home treatment with cryoprecipitate. Professor Blackburn agreed to write to both doctors to recommend commercial freeze-dried concentrate. Read more about The Reference Centre Directors noted that Drs Dormandy and Delamore had patients on home treatment with cryoprecipitate. Professor Blackburn agreed to write to both doctors to recommend commercial freeze-dried concentrate.